Free signup for more
- Track your favorite companies
- Receive email alerts for new filings
- Personalized dashboard of news and more
- Access all data and search results
Key to changes
?
Text removedfrom 2017 FY- Text added to 2018 FY
Content analysis
?Positive | |
Negative | |
Uncertain | |
Constraining | |
Legalese | |
Litigous | |
Readability |
H.S. sophomore Avg
|
Content analysis
?Positive | |
Negative | |
Uncertain | |
Constraining | |
Legalese | |
Litigous | |
Readability |
H.S. sophomore Avg
|
New words:
abraxane®, abrogating, accident, ADC, ANPRM, anticorruption, APAC, arm, ASCT, Asthenia, avadomide, axicabtagene, Azymetric, AzymetricTM, Baiji, basal, Basel, begun, belvarafenib, benchmarking, binimetinib, bispecific, blastoid, Blueprint, bottleneck, BRAFTOVI, bulk, caption, carryforward, CBL, cerebral, channel, cHL, CI, ciloleucel, classical, cloud, CMC, CMV, cobimetinib, comment, conjugate, constraint, coordinated, copanlisib, CSCO, CSRC, CT, cyber, Deepening, Diego, disorder, doctrine, DOR, duvelisib, dysfunction, Easement, EFECT, EFECTTM, EHA, eleven, email, erosion, erythrodysesthesia, ESPP, evergreen, exploratory, expressly, extramedullary, extraordinary, faith, female, FIRRMA, floating, flux, forum, fourteen, Fujian, gastrointestinal, GBM, GDPR, Harmonisation, hematoma, HGOC, HHS, HKEx, Horvath, Huajian, Hunan, IB, ICH, IL, impressive, inapplicable, incentivize, infrequent, Innerway, internet, intraparenchymal, intravenously, IPI, IRC, IWWM, jiroveci, journal, killer, leveraging, LIBTAYO, liposome, load, mechanistically, MEKTOVI, Meniawy, merged, methyltransferase, MGMT, mRANO, MRR, narrative, neuroendocrine, NHC, Ningxia, NINLARO, NIPA, NK, NMPA, Nonemployee, Observatory, ODD, operationally, overtime, payee, peculiar, PET, PFS, ph, PJP, polymearase, poster, predecessor, radiographic, reactivation, redirected, replenishment, rescind, rescinded, resort, Ridgefield, ROU, Rulemaking, safeguarding, salvage, SAMR, Sanjeev, Sanofi, scedosporium, Scott, septic, Sereno, Shahneen, Shenzhou, shoulder, ShuangLu, shutdown, sintilimab, SNO, spring, subsidy, succeeding, swifter, tabular, tackle, TALZENNA, TEAE, Thirteen, toripalimab, traffic, TUOYI, TYVYT, UBC, UK, unbilled, uncommon, unilateral, unmethylated, unresectable, vaccine, variant, vertigo, virtually, wild, worsening, Wu, Xiaobin, YESCARTA, ZYME
Removed:
assured, backlog, BESP, borne, borrowing, built, charter, cohort, collectible, Daiichi, deep, delta, disposed, effectuate, emerged, fastest, founder, GSK, hairy, head, hoc, Ji, kill, leasing, lethargy, Li, mild, molecularly, month, neck, path, preventing, promise, rendered, repurchase, repurchased, restore, reversible, rural, Sankyo, simplifying, SIPO, stringent, survive, SYK, TPE, transcriptional, twelve, unify, VSOE, Xintaike
Valuein 2017 FY filing- Value in 2018 FY filing
Original filings
Filing view